158 related articles for article (PubMed ID: 10667727)
1. Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves.
Sodian R; Hoerstrup SP; Sperling JS; Martin DP; Daebritz S; Mayer JE; Vacanti JP
ASAIO J; 2000; 46(1):107-10. PubMed ID: 10667727
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering.
Sodian R; Sperling JS; Martin DP; Egozy A; Stock U; Mayer JE; Vacanti JP
Tissue Eng; 2000 Apr; 6(2):183-8. PubMed ID: 10941212
[TBL] [Abstract][Full Text] [Related]
3. Tissue engineering of heart valves: in vitro experiences.
Sodian R; Hoerstrup SP; Sperling JS; Daebritz SH; Martin DP; Schoen FJ; Vacanti JP; Mayer JE
Ann Thorac Surg; 2000 Jul; 70(1):140-4. PubMed ID: 10921698
[TBL] [Abstract][Full Text] [Related]
4. Superior Tissue Evolution in Slow-Degrading Scaffolds for Valvular Tissue Engineering.
Brugmans MM; Soekhradj-Soechit RS; van Geemen D; Cox M; Bouten CV; Baaijens FP; Driessen-Mol A
Tissue Eng Part A; 2016 Jan; 22(1-2):123-32. PubMed ID: 26466917
[TBL] [Abstract][Full Text] [Related]
5. Application of stereolithography for scaffold fabrication for tissue engineered heart valves.
Sodian R; Loebe M; Hein A; Martin DP; Hoerstrup SP; Potapov EV; Hausmann H; Lueth T; Hetzer R
ASAIO J; 2002; 48(1):12-6. PubMed ID: 11814091
[TBL] [Abstract][Full Text] [Related]
6. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta1.
Dvorin EL; Wylie-Sears J; Kaushal S; Martin DP; Bischoff J
Tissue Eng; 2003 Jun; 9(3):487-93. PubMed ID: 12857416
[TBL] [Abstract][Full Text] [Related]
8. Early in vivo experience with tissue-engineered trileaflet heart valves.
Sodian R; Hoerstrup SP; Sperling JS; Daebritz S; Martin DP; Moran AM; Kim BS; Schoen FJ; Vacanti JP; Mayer JE
Circulation; 2000 Nov; 102(19 Suppl 3):III22-9. PubMed ID: 11082357
[TBL] [Abstract][Full Text] [Related]
9. A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials.
Engelmayr GC; Hildebrand DK; Sutherland FW; Mayer JE; Sacks MS
Biomaterials; 2003 Jun; 24(14):2523-32. PubMed ID: 12695079
[TBL] [Abstract][Full Text] [Related]
10. Fetal tissue engineering: in vitro analysis of muscle constructs.
Fuchs JR; Pomerantseva I; Ochoa ER; Vacanti JP; Fauza DO
J Pediatr Surg; 2003 Sep; 38(9):1348-53. PubMed ID: 14523818
[TBL] [Abstract][Full Text] [Related]
11. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves.
Perry TE; Kaushal S; Sutherland FW; Guleserian KJ; Bischoff J; Sacks M; Mayer JE
Ann Thorac Surg; 2003 Mar; 75(3):761-7; discussion 767. PubMed ID: 12645690
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of poly-glycolic acid-based hybrid polymer starter matrices for in vitro tissue engineering.
Generali M; Kehl D; Capulli AK; Parker KK; Hoerstrup SP; Weber B
Colloids Surf B Biointerfaces; 2017 Oct; 158():203-212. PubMed ID: 28697435
[TBL] [Abstract][Full Text] [Related]
13. PGA (polyglycolic acid)-P4HB (poly-4-hydroxybutyrate)-Based Bioengineered Valves in the Rat Aortic Circulation.
Książek AA; Mitchell KJ; Cesarovic N; Schwarzwald CC; Hoerstrup SP; Weber B
J Heart Valve Dis; 2016 May; 25(3):380-388. PubMed ID: 27989051
[TBL] [Abstract][Full Text] [Related]
14. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
[TBL] [Abstract][Full Text] [Related]
15. Tissue engineering of autologous aorta using a new biodegradable polymer.
Shum-Tim D; Stock U; Hrkach J; Shinoka T; Lien J; Moses MA; Stamp A; Taylor G; Moran AM; Landis W; Langer R; Vacanti JP; Mayer JE
Ann Thorac Surg; 1999 Dec; 68(6):2298-304; discussion 2305. PubMed ID: 10617020
[TBL] [Abstract][Full Text] [Related]
16. Design and fabrication of three-dimensional scaffolds for tissue engineering of human heart valves.
Schaefermeier PK; Szymanski D; Weiss F; Fu P; Lueth T; Schmitz C; Meiser BM; Reichart B; Sodian R
Eur Surg Res; 2009; 42(1):49-53. PubMed ID: 18987474
[TBL] [Abstract][Full Text] [Related]
17. Poly-ε-caprolactone scaffold and reduced in vitro cell culture: beneficial effect on compaction and improved valvular tissue formation.
Brugmans MM; Driessen-Mol A; Rubbens MP; Cox MA; Baaijens FP
J Tissue Eng Regen Med; 2015 Dec; 9(12):E289-301. PubMed ID: 23677869
[TBL] [Abstract][Full Text] [Related]
18. Effect of biomimetic conditions on mechanical and structural integrity of PGA/P4HB and electrospun PCL scaffolds.
Klouda L; Vaz CM; Mol A; Baaijens FP; Bouten CV
J Mater Sci Mater Med; 2008 Mar; 19(3):1137-44. PubMed ID: 17701317
[TBL] [Abstract][Full Text] [Related]
19. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
[TBL] [Abstract][Full Text] [Related]
20. Tissue engineering heart valves: valve leaflet replacement study in a lamb model.
Shinoka T; Breuer CK; Tanel RE; Zund G; Miura T; Ma PX; Langer R; Vacanti JP; Mayer JE
Ann Thorac Surg; 1995 Dec; 60(6 Suppl):S513-6. PubMed ID: 8604922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
